Background: Hepatitis C diagnostics involve antibody screening and confirmation of current infection by detection of HCV RNA positivity. In screening instruments with fixed pipetting needle, there is a risk of sample carry-over contamination.
Objectives: The aim of this study was to evaluate the risk of such contamination in a proposed clinical setting.